| |
 |
|
Home > In Vitro Diagnostics > Strategic Planning > Leading Diagnostics Companies Strategic Directions
|
Leading Diagnostics Companies Strategic Directions
|
|
 |
 |
For each company, the report provides insightful strategic assessments, including:- Business, new product development, and marketing strategies.
- Anticipated acquisitions, joint ventures, and divestitures.
The companies analyzed in the report: Abbott, Bayer Diabetes, Beckman Coulter, Becton Dickinson, bioMerieux, Bio-Rad, J&J, Roche, Siemens, and Sysmex. Contains 65 pages
|
|
 |
| |
|
|
| |
|
|
|
Local PDF: $2450.00
Other Formats: Global PDF, Print
|
 |
| |
|
 |
| |
|
|
|